Publicacions en col·laboració amb investigadors/es de Hospital Universitario 12 de Octubre (43)

2024

  1. Corollary Discharge Dysfunction as a Possible Substrate of Anomalous Self-experiences in Schizophrenia

    Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1137-1146

2023

  1. Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 6, pp. 1379-1386

2022

  1. Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 116

2021

  1. Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis

    Schizophrenia Research, Vol. 229, pp. 102-111

  2. Search for schizophrenia and bipolar biotypes using functional network properties

    Brain and Behavior, Vol. 11, Núm. 12

2020

  1. Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?

    Journal of Psychiatry and Neuroscience, Vol. 45, Núm. 5, pp. 322-333

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2016

  1. Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 64, pp. 79-86

2014

  1. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 223-229

2013

  1. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

2011

  1. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients

    NeuroImage, Vol. 56, Núm. 1, pp. 45-51

  2. Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, Núm. 5, pp. 313-322

2010

  1. Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry

    Psychiatry Research - Neuroimaging, Vol. 184, Núm. 1, pp. 16-22

  2. Voxel-based morphometry comparison between first episodes of psychosis with and without evolution to schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 181, Núm. 3, pp. 204-210

2009

  1. Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 173, Núm. 2, pp. 88-93

2008

  1. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 1, pp. 257-266

  2. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)

    Genes, Brain and Behavior, Vol. 7, Núm. 7, pp. 796-801

2007

  1. Changes in cortical volume with olanzapine in chronic schizophrenia

    Pharmacopsychiatry, Vol. 40, Núm. 4, pp. 135-139

  2. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder

    European Psychiatry, Vol. 22, Núm. 8, pp. 505-512

  3. Effect of interleukin-1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, Núm. 8, pp. 1090-1093